期刊
ARTHRITIS CARE & RESEARCH
卷 64, 期 6, 页码 797-808出版社
WILEY
DOI: 10.1002/acr.21664
关键词
-
类别
资金
- UCB
- Abbott
- HGS/GSK
- Amgen
- Pfizer
- Lilly
- Bristol-Myers Squibb
- Genentech/Roche
- EMD Serono
- Neovacs
- Cephalon
- MedImmune
- Questcor
- Argos
- Ono
- Astellas
- Baxter
- RPS
- Takeda
- Human Genome Sciences/GlaxoSmithKline
- Parexel
- ViiV
- Novartis
- Genzyme
- Cubist
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice. The American College of Rheumatology is an independent, professional, medical and scientific society which does not guarantee, warrant, or endorse any commercial product or service.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据